Eli Lilly and Company's Fiscal Year is From January To December.
The item "Cash-Ratio" stands at 0.247 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Cash Ratio" stands at 0.247. This represents an increase of 171.76 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 73.20 percent compared to the value the year prior.
The 1 year change in percent is 73.20.
The 3 year change in percent is 40.98.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Cash Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash Ratio | 280,205,508,085.11 |
![]() | Novartis AG - Cash Ratio | 255,096,620,580.91 |